# Devon Energy Corp: financial statements, quarterly

DVN · NYSE · CIK 1090012 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dvn.md) · [Financials](/companies/dvn/financials.md) · [Filings](/companies/dvn/filings.md) · [Insiders](/companies/dvn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dvn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4,030](/filings/0000950170-24-121981.md) | [3,821 d](/filings/0001193125-26-056485.md) | [3,741](/filings/0000950170-25-065278.md) | [3,894](/filings/0000950170-25-103695.md) | [3,797](/filings/0001193125-25-268574.md) | [4,487 d](/filings/0001193125-26-056485.md) | [4,550](/filings/0001193125-26-208143.md) | [4,048](/filings/0001193125-26-334340.md) | [4,251](/filings/0001193125-25-268574.md) | [3,937 d](/filings/0001193125-26-056485.md) | [4,508](/filings/0001193125-26-208143.md) | [7,003](/filings/0001193125-26-334340.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [152](/filings/0000950170-24-121981.md) | [269 d](/filings/0001193125-26-056485.md) | [159](/filings/0000950170-25-065278.md) | [185](/filings/0000950170-25-103695.md) | [239](/filings/0001193125-25-268574.md) | [187 d](/filings/0001193125-26-056485.md) | [137](/filings/0001193125-26-208143.md) | [244](/filings/0001193125-26-334340.md) | [219](/filings/0001193125-25-268574.md) | [185 d](/filings/0001193125-26-056485.md) | [46.0](/filings/0001193125-26-208143.md) | [473](/filings/0001193125-26-334340.md) |
| Net income | $m | [910](/filings/0000950170-24-121981.md) | [1,144 d](/filings/0001104659-26-046005.md) | [596](/filings/0000950170-25-065278.md) | [844](/filings/0000950170-25-103695.md) | [812](/filings/0001193125-25-268574.md) | [641 d](/filings/0001104659-26-046005.md) | [494](/filings/0001193125-26-208143.md) | [899](/filings/0001193125-26-334340.md) | [687](/filings/0001193125-25-268574.md) | [562 d](/filings/0001193125-26-056485.md) | [120](/filings/0001193125-26-208143.md) | [1,911](/filings/0001193125-26-334340.md) |
| Diluted EPS | $ per share | [1.42](/filings/0000950170-24-121981.md) | not reported | [0.94](/filings/0000950170-25-065278.md) | [1.34](/filings/0000950170-25-103695.md) | [1.30](/filings/0001193125-25-268574.md) | not reported | [0.77](/filings/0001193125-26-208143.md) | [1.41](/filings/0001193125-26-334340.md) | [1.09](/filings/0001193125-25-268574.md) | not reported | [0.19](/filings/0001193125-26-208143.md) | [2.03](/filings/0001193125-26-334340.md) |
| Basic EPS | $ per share | [1.43](/filings/0000950170-24-121981.md) | not reported | [0.95](/filings/0000950170-25-065278.md) | [1.35](/filings/0000950170-25-103695.md) | [1.31](/filings/0001193125-25-268574.md) | not reported | [0.77](/filings/0001193125-26-208143.md) | [1.42](/filings/0001193125-26-334340.md) | [1.09](/filings/0001193125-25-268574.md) | not reported | [0.19](/filings/0001193125-26-208143.md) | [2.04](/filings/0001193125-26-334340.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Operating income: not reported
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.7](/filings/0000950170-24-121981.md) | [0.9](/filings/0001193125-26-056485.md) | [1.1](/filings/0000950170-25-065278.md) | [1.1](/filings/0000950170-25-103695.md) | [0.6](/filings/0001193125-25-268574.md) | [0.8](/filings/0001193125-26-056485.md) | [1.2](/filings/0001193125-26-208143.md) | [1.7](/filings/0001193125-26-334340.md) | [1.2](/filings/0001193125-25-268574.md) | [1.4](/filings/0001193125-26-056485.md) | [1.8](/filings/0001193125-26-208143.md) | [1.0](/filings/0001193125-26-334340.md) |
| Current assets | $bn | [3.2](/filings/0000950170-23-060838.md) | [3.2](/filings/0000950170-25-022844.md) | [3.4](/filings/0000950170-24-051757.md) | [3.4](/filings/0000950170-24-092424.md) | [3.2](/filings/0000950170-24-121981.md) | [3.4](/filings/0001193125-26-056485.md) | [3.9](/filings/0000950170-25-065278.md) | [4.3](/filings/0000950170-25-103695.md) | [3.9](/filings/0001193125-25-268574.md) | [4.0](/filings/0001193125-26-334340.md) | [4.8](/filings/0001193125-26-208143.md) | [5.0](/filings/0001193125-26-334340.md) |
| Total assets | $bn | [24.2](/filings/0000950170-23-060838.md) | [24.5](/filings/0001193125-26-056485.md) | [25.0](/filings/0000950170-25-065278.md) | [25.2](/filings/0000950170-25-103695.md) | [30.3](/filings/0001193125-25-268574.md) | [30.5](/filings/0001193125-26-056485.md) | [30.9](/filings/0001193125-26-208143.md) | [31.4](/filings/0001193125-26-334340.md) | [31.2](/filings/0001193125-25-268574.md) | [31.6](/filings/0001193125-26-334340.md) | [32.5](/filings/0001193125-26-208143.md) | [70.9](/filings/0001193125-26-334340.md) |
| Current liabilities | $bn | [3.3](/filings/0000950170-23-060838.md) | [2.9](/filings/0000950170-25-022844.md) | [3.3](/filings/0000950170-24-051757.md) | [3.0](/filings/0000950170-24-092424.md) | [2.9](/filings/0000950170-24-121981.md) | [3.3](/filings/0001193125-26-056485.md) | [3.6](/filings/0000950170-25-065278.md) | [3.5](/filings/0000950170-25-103695.md) | [4.0](/filings/0001193125-25-268574.md) | [4.1](/filings/0001193125-26-334340.md) | [4.7](/filings/0001193125-26-208143.md) | [7.0](/filings/0001193125-26-334340.md) |
| Long-term debt | $bn | [5.7](/filings/0000950170-23-060838.md) | [5.7](/filings/0000950170-25-022844.md) | [5.7](/filings/0000950170-24-051757.md) | [5.7](/filings/0000950170-24-092424.md) | [8.9](/filings/0000950170-24-121981.md) | [8.4](/filings/0001193125-26-056485.md) | [8.4](/filings/0000950170-25-065278.md) | [8.4](/filings/0000950170-25-103695.md) | [7.4](/filings/0001193125-25-268574.md) | [7.4](/filings/0001193125-26-334340.md) | [7.4](/filings/0001193125-26-208143.md) | [9.9](/filings/0001193125-26-334340.md) |
| Current portion of debt | $bn | [0.5](/filings/0000950170-23-060838.md) | [0.5](/filings/0000950170-25-022844.md) | [0.5](/filings/0000950170-24-051757.md) | [0.5](/filings/0000950170-24-092424.md) | [0.0](/filings/0000950170-24-121981.md) | [0.5](/filings/0001193125-26-056485.md) | [0.5](/filings/0000950170-25-065278.md) | [0.5](/filings/0000950170-25-103695.md) | [1.0](/filings/0001193125-25-268574.md) | [1.0](/filings/0001193125-26-334340.md) | [1.0](/filings/0001193125-26-208143.md) | [1.5](/filings/0001193125-26-334340.md) |
| Short-term borrowings | $bn | [0.5](/filings/0000950170-23-060838.md) | [0.5](/filings/0000950170-25-022844.md) | [0.5](/filings/0000950170-24-051757.md) | [0.5](/filings/0000950170-24-092424.md) | [0.0](/filings/0000950170-24-121981.md) | [0.5](/filings/0001193125-26-056485.md) | [0.5](/filings/0000950170-25-065278.md) | [0.5](/filings/0000950170-25-103695.md) | [1.0](/filings/0001193125-25-268574.md) | [1.0](/filings/0001193125-26-334340.md) | [1.0](/filings/0001193125-26-208143.md) | [1.5](/filings/0001193125-26-334340.md) |
| Shareholders' equity | $bn | [11.6](/filings/0000950170-23-060838.md) | [12.1](/filings/0000950170-25-022844.md) | [12.2](/filings/0000950170-24-051757.md) | [12.6](/filings/0000950170-24-092424.md) | [14.3](/filings/0000950170-24-121981.md) | [14.5](/filings/0001193125-26-056485.md) | [14.5](/filings/0000950170-25-065278.md) | [15.1](/filings/0000950170-25-103695.md) | [15.4](/filings/0001193125-25-268574.md) | [15.5](/filings/0001193125-26-334340.md) | [15.4](/filings/0001193125-26-208143.md) | [41.7](/filings/0001193125-26-334340.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,725](/filings/0000950170-24-121981.md) | [1,737 d](/filings/0001193125-26-056485.md) | [1,738](/filings/0000950170-25-065278.md) | [1,535](/filings/0000950170-25-103695.md) | [1,663](/filings/0001193125-25-268574.md) | [1,664 d](/filings/0001193125-26-056485.md) | [1,942](/filings/0001193125-26-208143.md) | [1,545](/filings/0001193125-26-334340.md) | [1,690](/filings/0001193125-25-268574.md) | [1,534 d](/filings/0001193125-26-056485.md) | [1,655](/filings/0001193125-26-208143.md) | [3,674](/filings/0001193125-26-334340.md) |
| Capital expenditure | $m | [882](/filings/0000950170-24-121981.md) | [910 d](/filings/0001193125-26-056485.md) | [894](/filings/0000950170-25-065278.md) | [948](/filings/0000950170-25-103695.md) | [877](/filings/0001193125-25-268574.md) | [926 d](/filings/0001193125-26-056485.md) | [934](/filings/0001193125-26-208143.md) | [956](/filings/0001193125-26-334340.md) | [870](/filings/0001193125-25-268574.md) | [832 d](/filings/0001193125-26-056485.md) | [839](/filings/0001193125-26-208143.md) | [1,318](/filings/0001193125-26-334340.md) |
| Dividends paid | $m | [312](/filings/0000950170-25-022844.md) | [488](/filings/0000950170-24-021781.md) | [299](/filings/0000950170-25-022844.md) | [223](/filings/0000950170-25-022844.md) | [272](/filings/0000950170-25-022844.md) | [143](/filings/0000950170-25-022844.md) | not reported | not reported | [151 d](/filings/0001193125-25-268574.md) | [(151) d](/filings/0001193125-26-334340.md) | not reported | not reported |
| Share repurchases | $m | [0.0](/filings/0000950170-24-121981.md) | [234 d](/filings/0001193125-26-056485.md) | [205](/filings/0000950170-25-065278.md) | [256](/filings/0000950170-25-103695.md) | [295](/filings/0001193125-25-268574.md) | [301 d](/filings/0001193125-26-056485.md) | [301](/filings/0001193125-26-208143.md) | [249](/filings/0001193125-26-334340.md) | [250](/filings/0001193125-25-268574.md) | [250 d](/filings/0001193125-26-056485.md) | [69.0](/filings/0001193125-26-208143.md) | [197](/filings/0001193125-26-334340.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [651](/filings/0000950170-23-060838.md) | [647](/filings/0000950170-24-051757.md) | [639](/filings/0000950170-24-092424.md) | [639](/filings/0000950170-24-121981.md) | [632](/filings/0000950170-25-065278.md) | [628](/filings/0000950170-25-103695.md) | [623](/filings/0001193125-25-268574.md) | [645](/filings/0001193125-26-208143.md) | [636](/filings/0001193125-26-334340.md) | [629](/filings/0001193125-25-268574.md) | [618](/filings/0001193125-26-208143.md) | [940](/filings/0001193125-26-334340.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,100,000,000 at 2026-07-22, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-334340.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.